Board of Lincoln Pharmaceuticals approved proposal for delisting shares from Ahmedabad Stock Exchange
With effect from 24 November 2016Lincoln Pharmaceuticals announced that pursuant to the application made by the Company to ASEL for voluntary delisting of its Equity shares as per the provision of SEBI (Delisting of Equity Shares) Regulations, 2009. ASEL has vide its letter dated 23 November 2016 granted the approval for delisting of Equity Shares of the Company and accordingly the Equity shares of the company stand de-listed from ASEL with effect from 24 November 2016.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)